CELL AND GENE THERAPY INSIGHTS

Volume 3 Issue 6

Cell and Gene Therapy Insights Volume 3 Issue 6

Featuring

Issue Spotlight: Overcoming Downstream Bottlenecks
Other articles

Overcoming Downstream Bottlenecks

Expert Insight

Considerations for the bioprocessing, manufacture and translation of extracellular vesicles for therapeutic applications

Considerations for the bioprocessing, manufacture and translation of extracellular vesicles for therapeutic applications

Owen Davies, Qasim Rafiq

20 November 2017

Advances and challenges in umbilical cord blood and tissue bioprocessing: procurement and storage

Advances and challenges in umbilical cord blood and tissue bioprocessing: procurement and storage

L Parker, S Mansfield, K Sneddon et al.

Bioprocess engineering strategies for autologous human MSC-based therapies: one size does not fit all

Bioprocess engineering strategies for autologous human MSC-based therapies: one size does not fit all

Ioannis Papantoniou, Toon Lambrechts, Jean-Marie Aerts

Challenges and advances in scale-up of label-free downstream processing for allogeneic cell therapies

Challenges and advances in scale-up of label-free downstream processing for allogeneic cell therapies

F Masri, M Hoeve, P de Sousa et al.

Innovator Insight

The importance of fill & finish in the commercialization of your cell & gene therapy

The importance of fill & finish in the commercialization of your cell & gene therapy

Jean-Sebastien Parisse

Interview

Advances in the development of bioprocesses for vaccines and viral vectors for gene therapy

Advances in the development of bioprocesses for vaccines and viral vectors for gene therapy

Manuel Carrondo

Journal articles

Expert Insight

Cell therapy post-production technologies: a select review of key innovations in the field

Cell therapy post-production technologies: a select review of key innovations in the field

Maria Thompson, Brian Schryver, Rolf Ehrhardt

Commercial Insights

Cell & Gene Therapy Commercial Insight – July 2017

Cell & Gene Therapy Commercial Insight – July 2017

Mark Curtis, Richard Philipson